Solid Biosciences is approaching key catalysts in DMD gene therapy, with SGT-003 showing promising early safety and efficacy signals. The evolving DMD landscape, especially safety concerns with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results